https://www.marketscreener.com/quote/stock/CHUGAI-PHARMACEUTICAL-CO--6491165/news/Chugai-Pharmaceutical-EMA-and-FDA-Accept-Marketing-Applications-for-Chugai-s-Satralizumab-in-Neuro-29479133/?utm_source=telegram&utm_medium=social&utm_campaign=share